Takeda Pharmaceutical (TAK) Asset Writedowns and Impairment (2018 - 2026)
Takeda Pharmaceutical (TAK) reported Asset Writedowns and Impairment of $188.2 million for the quarter ended Jun 30, 2026, compared with $16.29 million a year earlier and down 42.0% from the prior quarter.
Takeda Pharmaceutical (TAK) Asset Writedowns and Impairment (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's Asset Writedowns and Impairment came in at $1.14 billion, up 108.6% year-over-year; for the year ended Mar 31, 2026, it came in at $968.02 million, up 38.4% from the prior year.
- Asset Writedowns and Impairment has a five-year compound annual growth rate of 32.2% (years ended Mar 2021 to Mar 2026).
- By year, Asset Writedowns and Impairment came in at $699.35 million in the year ended Mar 31, 2025 (-32.8%), $1.04 billion in the year ended Mar 31, 2024 (+118.2%), $476.66 million in the year ended Mar 31, 2023 (-1.8%) and $485.56 million in the year ended Mar 31, 2022 (+102.2%).
- Five-year quarterly Asset Writedowns and Impairment spans a low of $14.22 million in the quarter ended Dec 31, 2024 and a high of $823.13 million in the quarter ended Sep 30, 2023.
- Year over year, Asset Writedowns and Impairment gained in three of the last seven quarters, with growth averaging 148.9%.
- The high point for year-over-year Asset Writedowns and Impairment in five years was the quarter ended Sep 30, 2025 (growth of 752.8%); the low point was the quarter ended Sep 30, 2024 (a decline of 91.8%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $324.73 million (quarter ended Mar 31, 2026), $49.69 million (quarter ended Dec 31, 2025) and $575.42 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 188.20 Mn |
| Mar 31, 2026 | 324.73 Mn |
| Dec 31, 2025 | 49.69 Mn |
| Sep 30, 2025 | 575.42 Mn |
| Jun 30, 2025 | 16.29 Mn |
| Mar 31, 2025 | 447.69 Mn |
| Dec 31, 2024 | 14.22 Mn |
| Sep 30, 2024 | 67.48 Mn |
| Jun 30, 2024 | 167.02 Mn |
| Mar 31, 2024 | 106.18 Mn |
| Dec 31, 2023 | 51.27 Mn |
| Sep 30, 2023 | 823.13 Mn |
| Jun 30, 2023 | 57.13 Mn |
| Mar 31, 2023 | 169.53 Mn |
| Dec 31, 2022 | 42.60 Mn |
| Sep 30, 2022 | 157.21 Mn |
| Jun 30, 2022 | 110.09 Mn |
| Jun 30, 2021 | 484,155.96 |
| Mar 31, 2021 | 144.87 Mn |
| Jun 30, 2020 | 69.34 Mn |
Takeda Pharmaceutical Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();